PRESS INQUIRIES

Press Releases

Mapp Bio in the News

antibody
MappBio Announces Contract with BARDA for Sudan Ebolavirus Medical Countermeasure

September 28, 2018

Mapp Bio Press Release
MappBio Announces Contracts with BARDA for ZMappTM and Additional Filovirus Medical Countermeasures

September 29, 2017

antibody
Researchers Discover First Human Antibodies That Work Against All Ebolaviruses

May 19, 2017

antibody
Researchers develop Marburg virus treatment effective five days after infection

April 5, 2017

Mapp Bio
LeafBio Announces NEJM Publication of ZMapp™ Clinical Trial

October 13, 2016

Mapp Bio Receives HHS Funding for Expanded Access Protocol for Ebola Treatment
Mapp Bio Receives HHS Funding for Expanded Access Protocol for Ebola Treatment

August 8, 2016

Mapp Bio
LeafBio Announces Conclusion of ZMapp™ Clinical Trial

February 23, 2016

dreamstime_s_45476267
Clinical Trials Begin on Antibody-based Prevention of HIV and Genital Herpes

January 7, 2016

Press Release
ZMapp™ is Granted Orphan Medicinal Product Designation by the EMA

October 15, 2015

leafbio_logo-print-blue
ZMapp™ is Granted Fast Track Status by the FDA

September 17, 2015

canada
Government of Canada strengthens Ebola preparedness for Canadians

June 10, 2015

pharma
LeafBio Announces Acceptance of Investigational New Drug Application for Ebola Therapy ZMapp™

February 27, 2015

© 2017 Mapp Biopharmaceautical - Leaf Bio. All Rights Reserved.